How should the oral cefadroxil dose (1 g twice daily) be adjusted for an adult with an eGFR of 10 mL/min/1.73 m²?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cefadroxil Dose Adjustment for eGFR 10 mL/min/1.73 m²

For a patient with eGFR of 10 mL/min/1.73 m², reduce cefadroxil from 1 gram twice daily to 500 mg every 36 hours after an initial loading dose of 1000 mg.

Dosing Algorithm Based on FDA Label

The FDA-approved cefadroxil label provides explicit dosing guidance for renal impairment 1:

Initial dose: 1000 mg (loading dose)

Maintenance dosing by creatinine clearance:

  • CrCl 0-10 mL/min: 500 mg every 36 hours
  • CrCl 10-25 mL/min: 500 mg every 24 hours
  • CrCl 25-50 mL/min: 500 mg every 12 hours
  • CrCl >50 mL/min: No adjustment needed

With an eGFR of 10 mL/min/1.73 m², this patient falls into the most severe renal impairment category (0-10 mL/min range), requiring the maximum dosing interval extension.

Rationale and Pharmacokinetic Considerations

Cefadroxil is substantially excreted by the kidney 1, making dose adjustment critical to prevent drug accumulation and potential toxicity in severe renal impairment. Research demonstrates that elimination half-life increases dramatically from 1.4 hours in normal renal function to 25.5 hours in severe chronic renal failure 2. Peak serum concentrations also become more variable and elevated (12-57 mg/L) as renal function declines 3.

Despite severe renal impairment, urine concentrations remain adequate to treat susceptible bacteria even with adjusted dosing 3. The apparent volume of distribution (0.28-0.31 L/kg) remains stable across renal function levels 3, 2, but plasma elimination becomes heavily dependent on creatinine clearance with minimal nonrenal clearance 3.

Important Clinical Caveats

Use eGFR appropriately for dosing decisions: While the KDOQI guidelines note that validated eGFR equations using serum creatinine are appropriate for most drug dosing scenarios 4, the FDA label uses creatinine clearance terminology. For practical purposes, eGFR of 10 mL/min/1.73 m² can be used interchangeably with CrCl of 10 mL/min for this dosing decision 4.

Monitor for drug accumulation: The extended 36-hour interval is necessary because tubular secretion (normally present at higher GFR levels) is minimal when CrCl falls below 10 mL/min 3. Without this adjustment, significant drug accumulation will occur 1.

Dialysis considerations: If this patient progresses to hemodialysis, cefadroxil serum concentrations decrease by approximately 75% during a 6-8 hour dialysis session 2. Supplemental dosing after dialysis would then be required.

Elderly patients: Given that cefadroxil is substantially renally excreted, elderly patients with age-related decline in renal function require particular attention to dose adjustment 1. The dosing schedule above applies regardless of age when eGFR is 10 mL/min/1.73 m².

Related Questions

What is the appropriate dosing and titration strategy for fentanyl transdermal patches in patients with moderate to severe renal impairment (eGFR <30 mL/min/1.73 m² or on dialysis)?
In a 63-year-old man with normal sinus rhythm, occasional brief palpitations, exertional dyspnea with pleuritic chest discomfort, mild renal impairment (eGFR 55 mL/min/1.73 m², creatinine 1.33 mg/dL), and blood pressure only mildly controlled on losartan 100 mg, what are the appropriate diagnostic and therapeutic steps?
Can a 30 mg dose of ketorolac (Toradol) be administered to a patient with impaired renal function (BUN 31 mg/dL, creatinine 1.85 mg/dL, eGFR 44 mL/min)?
What is the appropriate renal dose of oral cefadroxil for a 50‑year‑old male with type 2 diabetes mellitus, diabetic nephropathy, estimated glomerular filtration rate 5–7 mL/min (creatinine 800–900 µmol/L) on peritoneal dialysis for a diabetic foot wound?
What are the recommended dosing adjustments and precautions for metoclopramide in patients with impaired renal function (eGFR 30‑60 mL/min/1.73 m² and eGFR < 30 mL/min/1.73 m²)?
In an adult male with total testosterone and calculated free testosterone below the lower reference range, what should be done?
I have bilateral pinky weakness and lower back pain that worsens with standing or running and improves when sitting; what could be causing these symptoms?
What are the causes of a hiatal hernia?
Is my free testosterone level borderline low, and what steps should be taken to evaluate and manage it?
What does a low thyroid‑stimulating hormone (TSH) of 0.02 µIU/mL with a normal free thyroxine (T4) of 1.3 ng/dL indicate, and what is the appropriate management?
How should we safely discontinue the monthly Abilify (aripiprazole) 400 mg injection after two doses in a patient who was not previously taking oral Abilify (aripiprazole) tablet?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.